ROSSINI, BERNARDO
 Distribuzione geografica
Continente #
NA - Nord America 228
EU - Europa 119
AS - Asia 85
AF - Africa 1
SA - Sud America 1
Totale 434
Nazione #
US - Stati Uniti d'America 226
IT - Italia 64
CN - Cina 28
SE - Svezia 22
HK - Hong Kong 19
SG - Singapore 18
RU - Federazione Russa 9
IN - India 8
DE - Germania 6
IE - Irlanda 4
BE - Belgio 3
GB - Regno Unito 3
TR - Turchia 3
TW - Taiwan 3
FI - Finlandia 2
FR - Francia 2
JP - Giappone 2
TH - Thailandia 2
BR - Brasile 1
CA - Canada 1
DZ - Algeria 1
ES - Italia 1
IR - Iran 1
JM - Giamaica 1
LT - Lituania 1
NL - Olanda 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 434
Città #
Fairfield 41
Woodbridge 21
Chandler 19
Nyköping 17
Ashburn 16
Singapore 16
Bari 15
Ann Arbor 13
Seattle 12
Cambridge 9
Houston 9
Milan 6
Roxbury 5
Wilmington 5
Alcamo 4
Beijing 4
Des Moines 4
Dublin 4
Inglewood 4
Lawrence 4
Los Angeles 4
Boardman 3
Brussels 3
Dearborn 3
Florence 3
Guangzhou 3
Istanbul 3
Modugno 3
Munich 3
Verona 3
Wuxi 3
Bengaluru 2
Chiang Mai 2
Fragagnano 2
Grafing 2
Helsinki 2
Itri 2
Jiaxing 2
Leawood 2
Moscow 2
Palermo 2
Pune 2
Redwood City 2
San Diego 2
Sant'Andrea Bagni 2
Santa Clara 2
Shanghai 2
Taipei 2
Washington 2
West Jordan 2
Ardabil 1
Bologna 1
Bratislava 1
Brooklyn 1
Bunker Hill 1
Chennai 1
Constantine 1
Córdoba 1
Florianópolis 1
Fuzhou 1
Groningen 1
Hebei 1
Hefei 1
Hong Kong 1
Leverano 1
London 1
Manila 1
Montreal 1
Mumbai 1
Nanjing 1
Naples 1
New Taipei 1
Nuremberg 1
Obata 1
Paris 1
Queens 1
Romola 1
San Mateo 1
Shenyang 1
Shenzhen 1
Shijiazhuang 1
Zhengzhou 1
Totale 332
Nome #
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 120
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 102
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 93
Is whole body low dose CT still necessary in the era of 18F-FDG PET/CT for the assessment of bone disease in multiple myeloma patients? 52
DARA-VD VERSUS DARA-RD AS SALVAGE THERAPY FOR PATIENTS WITH MYELOMA. INITIAL FOLLOW-UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY RETE EMATOLOGICA PUGLIESE 48
Primary, Bilateral and Diffuse Renal Non-Hodgkin's Lymphoma in a Young Woman Suffering from Turner Syndrome 33
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials 9
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by “rete ematologica pugliese” 3
Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’ 2
Real-Life Multicentre Study on 547 Patients Affected By Waldenstrom Macroglobulinemia Treated with Chemo-Immunotherapy: Which Is the Best and Most Used First-Line Treatment? 1
Totale 463
Categoria #
all - tutte 2.117
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.117


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 0 7 6 7 9 3 1 3
2020/202140 1 2 2 2 9 2 0 5 5 3 7 2
2021/202247 2 2 3 3 3 5 4 4 2 1 8 10
2022/202366 6 10 5 3 5 10 4 7 15 0 0 1
2023/2024106 8 6 23 3 11 12 22 2 0 6 5 8
2024/202582 19 7 13 17 6 20 0 0 0 0 0 0
Totale 463